{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:30:38Z","timestamp":1777779038165,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1208\/s12249-015-0373-2","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T18:51:38Z","timestamp":1437677498000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating"],"prefix":"10.1208","volume":"17","author":[{"given":"Nicole","family":"Jedinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Schrank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlheinz","family":"Breinh\u00e4lter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Khinast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Roblegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"issue":"5","key":"373_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03639045.2012.680468","volume":"39","author":"DJ Mastropietro","year":"2013","unstructured":"Mastropietro DJ, Omidian H. Current approaches in tamper-resistant and abuse-deterrent formulations. Drug Dev Ind Pharm. 2013;39(5):1\u201314.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"373_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11926-008-0003-z","volume":"10","author":"N Katz","year":"2008","unstructured":"Katz N. Abuse-deterrent opioid formulations: are they a pipe dream? Curr Rheumatol Rep. 2008;10(1):11\u20138.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"373_CR3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00003088-199835030-00002","volume":"35","author":"GK Gourlay","year":"1998","unstructured":"Gourlay GK. Sustained relief of chronic pain: pharmacokinetics of sustained release morphine. Clin Pharmacokinet. 1998;35(3):173\u201390.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"373_CR4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1023\/A:1015970512368","volume":"7","author":"JP Skelly","year":"1990","unstructured":"Skelly JP, Amidon GL, Barr WH, Benet LZ, Carter JE, Robinson JR, et al. In vitro and in vivo testing and correlation for oral controlled\/modified-release dosage forms. Pharm Res. 1990;7(9):975\u201382.","journal-title":"Pharm Res"},{"issue":"10","key":"373_CR5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/03639040701377292","volume":"33","author":"M Walden","year":"2007","unstructured":"Walden M, Nicholls FA, Smith KJ, Tucker GT. The effect of ethanol on the release of opioids from oral prolonged-release preparations. Drug Dev Ind Pharm. 2007;33(10):1101\u201311.","journal-title":"Drug Dev Ind Pharm"},{"issue":"S2","key":"373_CR6","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1111\/j.1526-4637.2009.00672.x","volume":"10","author":"LR Webster","year":"2009","unstructured":"Webster LR. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations. Pain Med. 2009;10(S2):S124\u2013S33.","journal-title":"Pain Med"},{"issue":"3","key":"373_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1517\/13543780902751622","volume":"18","author":"LR Webster","year":"2009","unstructured":"Webster LR, Bath B, Medve RA. Opioid formulations in development designed to curtail abuse: who is the target? Expert Opin Investig Drugs. 2009;18(3):255\u201363.","journal-title":"Expert Opin Investig Drugs"},{"key":"373_CR8","unstructured":"FDA guidance for industry abuse-deterrent opioids\u2014evaluation and labeling 2015 [11 Jun 2015]. Available from: www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM334743.pdf ."},{"issue":"2","key":"373_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1773-2247(13)50017-7","volume":"23","author":"C Herry","year":"2013","unstructured":"Herry C, Monti A, Vauzelle-Kervroedan F, Oury P, Michel L. Reducing abuse of orally administered prescription opioids using formulation technologies. J Drug Deliv Sci Tech. 2013;23(2):103\u201310.","journal-title":"J Drug Deliv Sci Tech"},{"key":"373_CR10","unstructured":"FDA approves abuse-deterrent labeling for reformulated OxyContin [12 Feb 2015]. Available from: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm348252.htm ."},{"key":"373_CR11","unstructured":"FDA approves Targiniq ER with abuse-deterrent properties [12 Feb 2015]. Available from: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm406290.htm ."},{"key":"373_CR12","unstructured":"FDA approves labeling with abuse-deterrent features for third extended-release opioid analgesic [12 Feb 2015]. Available from: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm419288.htm ."},{"key":"373_CR13","unstructured":"Purdue Pharma L.P. receives FDA approval for HysinglaTM ER (hydrocodone bitartrate) extended-release tablets CII, a once-daily opioid analgesic formulated with abuse-deterrent properties [04 Feb 2015]. Available from: http:\/\/www.purduepharma.com\/news-media\/2014\/11\/purdue-pharma-l-p-receives-fda-approval-for-hysinglatm-er-hydrocodone-bitartrate-extended-release-tablets-cii-a-once-daily-opioid-analgesic-formulated-with-abuse-deterrent-properties\/ ."},{"key":"373_CR14","unstructured":"Zogenix receives FDA approval for ZohydroTM ER (hydrocodone bitartrate) extended-release capsules [04 Feb 2015]. Available from: http:\/\/ir.zogenix.com\/phoenix.zhtml?c=220862&p=irol-newsArticle&ID=1868848 ."},{"issue":"1\u20132","key":"373_CR15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.drugalcdep.2012.05.013","volume":"126","author":"SK Vosburg","year":"2012","unstructured":"Vosburg SK, Jones JD, Manubay JM, Ashworth JB, Benedek IH, Comer SD. Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug Alcohol Depend. 2012;126(1\u20132):206\u201315.","journal-title":"Drug Alcohol Depend"},{"key":"373_CR16","unstructured":"Sokolowska M. FDA meeting on ADF\u2014development and evaluation of abuse deterrent opioid formulations, part 1 2014 [12 Feb 2015]. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/NewsEvents\/UCM422383.pdf ."},{"issue":"2","key":"373_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejpb.2014.02.008","volume":"87","author":"N Jedinger","year":"2014","unstructured":"Jedinger N, Khinast J, Roblegg E. The design of controlled-release formulations resistant to alcohol-induced dose dumping\u2014a review. Eur J Pharm Biopharm. 2014;87(2):217\u201326.","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"373_CR18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","volume":"94","author":"JM White","year":"1999","unstructured":"White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94(7):961\u201372.","journal-title":"Addiction"},{"key":"373_CR19","unstructured":"Wening K, Barnscheid L, Schwier S, Gei\u00dfler A, inventors; Gr\u00fcnenthal GmbH, assignee. Tamper-resistant dosage form containing ethylene-vinyl acetate polymer patent. US 2015\/0017250 A1. 2015."},{"issue":"8","key":"373_CR20","first-page":"76","volume":"12","author":"JH Bartholomaeus","year":"2012","unstructured":"Bartholomaeus JH, Ashworth JB, Stahlberg H-J, Galia E, Strothmann K. Innovative formulation technology protecting intended drug action. Drug Dev Deliv. 2012;12(8):76\u201381.","journal-title":"Drug Dev Deliv"},{"issue":"2","key":"373_CR21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1208\/s12249-013-9946-0","volume":"14","author":"J Khinast","year":"2013","unstructured":"Khinast J, Baumgartner R, Roblegg E. Nano-extrusion: a one-step process for manufacturing of solid nanoparticle formulations directly from the liquid phase. AAPS PharmSciTech. 2013;14(2):601\u20134.","journal-title":"AAPS PharmSciTech"},{"key":"373_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.10.008","volume":"477","author":"R Baumgartner","year":"2014","unstructured":"Baumgartner R, Eitzlmayr A, Matsko N, Tetyczka C, Khinast J, Roblegg E. Nano-extrusion: a promising tool for continuous manufacturing of solid nano-formulations. Int J Pharm. 2014;477:1\u201311.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"373_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2014.03.022","volume":"466","author":"D Treffer","year":"2014","unstructured":"Treffer D, Wahl PR, H\u00f6rmann TR, Markl D, Schrank S, Jones I, et al. In-line implementation of an image-based particle size measurement tool to monitor hot-melt extruded pellets. Int J Pharm. 2014;466(1\u20132):181\u20139.","journal-title":"Int J Pharm"},{"issue":"2","key":"373_CR24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejpb.2011.04.007","volume":"79","author":"S Bialleck","year":"2011","unstructured":"Bialleck S, Rein H. Preparation of starch-based pellets by hot-melt extrusion. Eur J Pharm Biopharm. 2011;79(2):440\u20138.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"373_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.04.001","volume":"169","author":"Y Rosiaux","year":"2013","unstructured":"Rosiaux Y, Muschert S, Chokshi R, Leclercq B, Siepmann F, Siepmann J. Ethanol-resistant polymeric film coatings for controlled drug delivery. J Control Release. 2013;169(1\u20132):1\u20139.","journal-title":"J Control Release"},{"issue":"(3, Part B)","key":"373_CR26","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ejpb.2013.07.014","volume":"85","author":"Y Rosiaux","year":"2013","unstructured":"Rosiaux Y, Velghe C, Muschert S, Chokshi R, Leclercq B, Siepmann F, et al. Ethanol-resistant ethylcellulose\/guar gum coatings\u2014importance of formulation parameters. Eur J Pharm Biopharm. 2013;85((3, Part B)):1250\u20138.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"373_CR27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11095-013-1194-1","volume":"31","author":"Y Rosiaux","year":"2014","unstructured":"Rosiaux Y, Velghe C, Muschert S, Chokshi R, Leclercq B, Siepmann F, et al. Mechanisms controlling theophylline release from ethanol-resistant coated pellets. Pharm Res. 2014;31(3):731\u201341.","journal-title":"Pharm Res"},{"issue":"6","key":"373_CR28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/01418619308225362","volume":"67","author":"PH Shipway","year":"1993","unstructured":"Shipway PH, Hutchings IM. Fracture of brittle spheres under compression and impact loading. I. Elastic stress distributions. Philos Mag A. 1993;67(6):1389\u2013404.","journal-title":"Philos Mag A"},{"key":"373_CR29","first-page":"64","volume":"20","author":"JW Moore","year":"1996","unstructured":"Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Techno. 1996;20:64\u201374.","journal-title":"Pharm Techno"},{"issue":"12","key":"373_CR30","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jps.2600561207","volume":"56","author":"AN Paruta","year":"1967","unstructured":"Paruta AN. Solubility profiles for antipyrine and aminopyrine in hydroalcoholic solutions. J Pharm Sci. 1967;56(12):1565\u20139.","journal-title":"J Pharm Sci"},{"key":"373_CR31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2015.02.022","volume":"92","author":"N Jedinger","year":"2015","unstructured":"Jedinger N, Schrank S, Mohr S, Feichtinger A, Khinast J, Roblegg E. Alcohol dose dumping: the influence of ethanol on hot-melt extruded pellets comprising solid lipids. Eur J Pharm Biopharm. 2015;92:83\u201395.","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"373_CR32","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/jps.2600831217","volume":"83","author":"A Li","year":"1994","unstructured":"Li A, Yalkowsky SH. Solubility of organic solutes in ethanol\/water mixtures. J Pharm Sci. 1994;83(12):1735\u201340.","journal-title":"J Pharm Sci"},{"issue":"3","key":"373_CR33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1208\/pt040333","volume":"4","author":"N Seedher","year":"2003","unstructured":"Seedher N, Bhatia S. Solubility enhancement of cox-2 inhibitors using various solvent systems. AAPS PharmSciTech. 2003;4(3):36\u201344.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"373_CR34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.carbpol.2012.08.008","volume":"91","author":"F Yu","year":"2013","unstructured":"Yu F, Prashantha K, Soulestin J, Lacrampe M-F, Krawczak P. Plasticized-starch\/poly (ethylene oxide) blends prepared by extrusion. Carbohyd Polym. 2013;91(1):253\u201361.","journal-title":"Carbohyd Polym"},{"issue":"12","key":"373_CR35","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.progpolymsci.2009.07.001","volume":"34","author":"H Liu","year":"2009","unstructured":"Liu H, Xie F, Yu L, Chen L, Li L. Thermal processing of starch-based polymers. Prog Polym Sci. 2009;34(12):1348\u201368.","journal-title":"Prog Polym Sci"},{"issue":"5","key":"373_CR36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.polymertesting.2003.11.001","volume":"23","author":"MJ Zohuriaan","year":"2004","unstructured":"Zohuriaan MJ, Shokrolahi F. Thermal studies on natural and modified gums. Polym Test. 2004;23(5):575\u20139.","journal-title":"Polym Test"},{"issue":"9\u201310","key":"373_CR37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/star.201400014","volume":"66","author":"T Kipping","year":"2014","unstructured":"Kipping T, Trindade R, Rein H. The use of hot-melt extruded corn starch matrices as drug carrier systems: a thermophysical characterization. Starch - St\u00e4rke. 2014;66(9\u201310):923\u201333.","journal-title":"Starch - St\u00e4rke"},{"issue":"2","key":"373_CR38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.carbpol.2008.12.027","volume":"77","author":"P Liu","year":"2009","unstructured":"Liu P, Yu L, Liu H, Chen L, Li L. Glass transition temperature of starch studied by a high-speed DSC. Carbohyd Polym. 2009;77(2):250\u20133.","journal-title":"Carbohyd Polym"},{"key":"373_CR39","unstructured":"Bialleck S. Herstellung von Polysaccharidpellets mittels Schmelzextrusion Bonn: Rheinische Friedrich-Wilhelms-Universit\u00e4t 2011. Available from: http:\/\/hss.ulb.uni-bonn.de\/2012\/2743\/2743.htm ."},{"issue":"3","key":"373_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.carbpol.2006.01.026","volume":"65","author":"H Liu","year":"2006","unstructured":"Liu H, Yu L, Xie F, Chen L. Gelatinization of cornstarch with different amylose\/amylopectin content. Carbohyd Polym. 2006;65(3):357\u201363.","journal-title":"Carbohyd Polym"},{"key":"373_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0040-6031(00)00358-0","volume":"357\u2013358","author":"CG Moth\u00e9","year":"2000","unstructured":"Moth\u00e9 CG, Rao MA. Thermal behavior of gum arabic in comparison with cashew gum. Thermochim Acta. 2000;357\u2013358:9\u201313.","journal-title":"Thermochim Acta"},{"key":"373_CR42","first-page":"1973","volume":"72","author":"GF Wauer","year":"2010","unstructured":"Wauer GF, Rein H. Solid solutions of tramadol-HCl based on starch. Pharm Ind. 2010;72:1973\u20139.","journal-title":"Pharm Ind"},{"issue":"1\u20133","key":"373_CR43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.molstruc.2011.01.062","volume":"993","author":"G Petru\u0161evski","year":"2011","unstructured":"Petru\u0161evski G, Ugarkovic S, Makreski P. Solid-state transformation of the pseudopolymorphic forms of codeine phosphate hemihydrate and codeine phosphate sesquihydrate monitored by vibrational spectroscopy and thermal analysis. J Mol Struct. 2011;993(1\u20133):328\u201335.","journal-title":"J Mol Struct"},{"issue":"5","key":"373_CR44","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/app.20768","volume":"93","author":"US Toti","year":"2004","unstructured":"Toti US, Soppimath KS, Mallikarjuna NN, Aminabhavi TM. Acrylamide-grafted-acacia gum polymer matrix tablets as erosion-controlled drug delivery systems. J Appl Polym Sci. 2004;93(5):2245\u201353.","journal-title":"J Appl Polym Sci"},{"issue":"1","key":"373_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0378-5173(94)00410-7","volume":"120","author":"MM Talukdar","year":"1995","unstructured":"Talukdar MM, Kinget R. Swelling and drug release behaviour of xanthan gum matrix tablets. Int J Pharm. 1995;120(1):63\u201372.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"373_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.02.007","volume":"296","author":"CW Vendruscolo","year":"2005","unstructured":"Vendruscolo CW, Andreazza IF, Ganter JLMS, Ferrero C, Bresolin TMB. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline. Int J Pharm. 2005;296(1\u20132):1\u201311.","journal-title":"Int J Pharm"},{"key":"373_CR47","unstructured":"FMC. BioPolymer Aquacoat\u00ae ARC [27 May 2013]. Available from: http:\/\/www.fmcbiopolymer.com\/Pharmaceutical\/Products\/NEWAquacoatARC.aspx ."},{"issue":"5","key":"373_CR48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/star.201100168","volume":"64","author":"S Bialleck","year":"2012","unstructured":"Bialleck S, Rein H. Drug release mechanisms of hot-melt extruded starch-based pellets. Starch - St\u00e4rke. 2012;64(5):408\u201319.","journal-title":"Starch - St\u00e4rke"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-015-0373-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-015-0373-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-015-0373-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:33:24Z","timestamp":1559619204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-015-0373-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1208\/s12249-015-0373-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]}}}